---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-129470"
form_type: "8-K"
ticker: "CTMX"
cik: "0001501989"
company_name: "CytomX Therapeutics, Inc."
filed_at: "2025-05-28T23:59:59+00:00"
generated_at: "2026-05-20T07:53:03.551307+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# CytomX regains Nasdaq minimum bid price compliance as of May 23, 2025

## Summary
- Nasdaq Staff notified company on May 27, 2025, of compliance regained.
- Closing price ≥ $1.00 for 10 consecutive trading days ended May 23, 2025.
- Resolves previous deficiency notice from February 24, 2025.
- Matter is now closed with no further action required.

## SEC filing metadata
- accession: 0001193125-25-129470
- form_type: 8-K
- ticker: CTMX
- cik: 0001501989
- company_name: CytomX Therapeutics, Inc.
- filed_at: 2025-05-28T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501989/000119312525129470/0001193125-25-129470-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501989/000119312525129470/d932298d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-129470
- JSON: https://secwatch.observer/filing/0001193125-25-129470.json
- Plain text: https://secwatch.observer/filing/0001193125-25-129470.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.